{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-21-003370","form_type":"8-K","ticker":"CMMB","cik":"0001534248","company_name":"Chemomab Therapeutics Ltd.","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.943578+00:00","generated_at":"2026-06-28T13:55:49.593404+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Chemomab Therapeutics files updated corporate presentation on systemic sclerosis","bullets":["Presentation dated November 3, 2021, focuses on systemic sclerosis (SSc) program.","No specific clinical data or financial results disclosed in the excerpt provided.","Live webinar held same day to discuss the updated presentation."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-21-003370","json":"https://secwatch.observer/filing/0001178913-21-003370.json","markdown":"https://secwatch.observer/filing/0001178913-21-003370.md","text":"https://secwatch.observer/filing/0001178913-21-003370.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534248/000117891321003370/0001178913-21-003370-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534248/000117891321003370/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:55:49.593404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}